The effect of glucocorticoids on fat and lean tissue masses in giant cell arteritis

Scandinavian Journal of Rheumatology

Volumn 27, Issue 2, 1998, Pages 106-111

  Nordborg, E ^a   Schaufelberger, C ^a   Bosaeus, I ^a  

^a SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Cushing syndrome; DXA; GCA; Glucocorticoids; Lean tissue; Obesity

Indexed keywords

CLODRONIC ACID; GLUCOCORTICOID; PREDNISONE;

ADULT; AGED; ARTERITIS; ARTICLE; BODY COMPOSITION; BODY FAT; CLINICAL ARTICLE; CLINICAL TRIAL; CORTICOSTEROID THERAPY; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; DRUG EFFECT; DUAL ENERGY X RAY ABSORPTIOMETRY; FEMALE; GIANT CELL ARTERITIS; HUMAN; LEAN BODY WEIGHT; MALE; OBESITY; PRIORITY JOURNAL; TREATMENT OUTCOME;

ADIPOSE TISSUE; AGED; BODY COMPOSITION; BODY MASS INDEX; BODY WEIGHT; DENSITOMETRY, X-RAY; DOUBLE-BLIND METHOD; FEMALE; FOLLOW-UP STUDIES; GLUCOCORTICOIDS; HUMANS; MALE; MIDDLE AGED; PREDNISONE; PROSPECTIVE STUDIES; TEMPORAL ARTERITIS;

EID: 0031945587     PISSN: 03009742     EISSN: None     Source Type: Journal    
DOI: 10.1080/030097498440967     Document Type: Article

References (23)

1. Rebuffé-Scrive M, Krotkiewski M, Ellerson J, Björntorp P. Muscle and adipose tissue morphology and metabolism in Cushing's syndrome. J Clin Endocrinol Metab 1988;67:1122-8.
2. Melby JC. Systemic corticosteroid therapy: pharmacology and endocrinologic considerations. Ann Intern Med 1974;81:505-9.
3. Axelrod L. Glucocorticoid therapy. Medicine 1976;55:39-44.
4. Nelson DH. Cushing's syndrome. In: De Groot LJ, ed. Endocrinology. Philadelphia: PA Saunders, 1989:1660-75.
5. Christy NP, Iatrogenic Cushing's syndrome. In: Christy, NP, ed. The Human Adrenal Cortex. New York: Harper and Row, 1971:395.
6. Williams ED, Henderson IS, Boddy K, Kennedy AC, Elliott HL, Haywood JK, et al. Whole-body elemental composition in patients with renal failure and after transplantation studied using total-body neutron-activation analysis. Eur J Clin Invest 1984;14:362-8.
7. Coles GA. Body composition in chronic renal failure. QJ Med 1972;161:25-47.
8. Wajchenberg BL, Bosco A, Marone MM, Levin S, Rocha M, Lerario AC, et al. Estimation of body fat and lean tissue distribution by dual energy X-ray absorptiometry and abdominal body fat evaluation by computed tomography in Cushing's disease. J Clin Endocrinol Metab 1995;80:2791-4.
9. Lönn L, Kvist H, Ernest I, Sjöström L. Changes in body composition and adipose tissue distribution after treatment of women with Cushing's syndrome. Metabolism 1994; 43:1517-22.
10. Horber FF, Zürcher RM, Herren H, Crivelli MA, Robotti G, Frey FJ. Altered body fat distribution in patients with glucocorticoid treatment and in patients on long-term dialysis. Am J Clin Nutr 1986;43:758-69.
11. Nordborg E, Schaufelberger C, Andersson R, Bosaeus I, Bengtsson BÅ. Ineffectiveness of cyclical oral clodronate on BMD in glucocorticoid-treated patients with giant cell arteritis. J Intern Med, (in press) 1997.
12. Bengtsson BÅ, Malmvall BE. The epidemiology of giant cell arteritis including temporal arteritis and polymyalgia rheumatica. Arthritis Rheum 1981;24:899-904.
13. Bradley JW. Distribution-free statistical tests. London: Prentice-Hall, 1968;68-86.
14. Björntorp P. Metabolic implications of body fat distribution. Diabetes Care 1991;14:1132-43.
15. Mayo-Smith W, Hayes CW, Biller BMK, Klibanski A, Rosenthal H, Rosenthal DI. Body fat distribution measured with CT: correlations in healthy subjects, patients with anorexia nervosa and patients with Cushing's syndrome. Radiology 1989;170:515-8.
16. Fried SK, Russel CD, Grausa NL, Brolin RE. Lipoprotein lipase regulation by insulin and glucocorticoid in subcutaneaus and omental adipose tissues of obese women and men. J Clin Invest 1993;92:2191-8.
17. Bonnegard M, Reynisdottir S, Marcus C, Stierna P, Arner P. Effect of glucocorticoid treatment on glucocorticoid receptor expression in human adipocytes. J Clin Endocrinol Metab 1995;80:3608-12.
18. Bujalska IJ, Kumar S, Stewart PM. Does central obesity reflect "Cushing's disease of the omentum"? Lancet 1997;349:1210-3.
19. Stewart PM. 11beta hydroxysteroid dehydrogenase implications for clinical medicine. Clin Endocrinol (Oxf) 1996;44:493-9.
20. Mårin P, Holmäng S, Gustafsson C, Jönsson L, Kvist H, Elander A, et al. Androgen treatment of abdominal obese men. Obes Res 1993;1:245-51.
21. Haarbo J, Marslew U, Gotfredsen A, Christiansen C. Postmenopausal hormone replacement therapy prevents central distribution of body fat after menopause. Metabolism 1991;40:1323-6
22. MacAdams MR, White RH, Chipps BE. Reduction in serum testosterone levels during chronic glucocorticoid therapy. Ann Intern Med 1986;104:648-51.
23. Reid IR, Wattie DJ, Evans MC, Stapleton JP. Testosterone therapy in glucocorticoid-treated men. Arch Intern Med 1996;156:1173-7.